ZNTL
Zentalis Pharmaceuticals, Inc.Company with tickers: ZNTL
CIK
1725160
CUSIP
98943L107
Shares Outstanding
71,186,348
Website
https://www.zentalis.com
Investor Relations
https://ir.zentalis.com/overview/default.aspx
13F Activity (30d)
9 filings
8 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-27 | 2026-05-22 | |
| 8-K | 2026-05-21 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-30 | 2026-06-16 | |
| 8-K | 2026-04-17 | — | |
| 8-K | 2026-04-09 | — | |
| 8-K | 2026-03-26 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-01-09 | 2026-01-06 | |
| 8-K | 2025-12-15 | — | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-08-26 | — | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-06-02 | 2025-05-31 | |
| 8-K | 2025-05-20 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-04-30 | 2025-06-17 | |
| 8-K | 2025-04-28 | 2025-04-27 | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-03-26 | — | |
| 8-K | 2025-03-17 | 2025-03-15 | |
| 8-K | 2025-01-29 | — | |
| 8-K | 2025-01-28 | 2025-01-22 | |
| 8-K/A | 2024-12-19 | 2024-12-17 | |
| 8-K | 2024-11-13 | 2024-11-12 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-09-16 | — | |
| 8-K | 2024-08-09 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-06-21 | — | |
| 8-K | 2024-06-03 | — | |
| 8-K | 2024-05-29 | 2024-05-24 | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-21 | |
| 8-K | 2024-04-11 | 2024-04-05 | |
| 8-K | 2024-04-09 | — | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-02-15 | 2024-02-12 | |
| 8-K | 2024-01-25 | 2024-01-19 | |
| 8-K | 2024-01-08 | 2024-01-05 | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-11-06 | — |
Showing 1–50 of 118 filings